Clinical Importance of estrogen reactivity in Hormone Receptor Positive HER2-Negative Breast Cancer

被引：0
|
作者：
Takeshita, Takashi [1 ]
Iwase, Hirotaka [1 ]
Takabe, Kazuaki [2 ]
机构：
[1] Kumamoto City Hosp, Kumamoto, Japan
[2] Roswell Pk Comprehens Canc Ctr, New York, NY USA
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1185
引用
收藏
页码：597 / 597
页数：1
相关论文
共 50 条
  • [31] Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer
    Gaia Griguolo
    Maria Vittoria Dieci
    Laia Paré
    Federica Miglietta
    Daniele Giulio Generali
    Antonio Frassoldati
    Luigi Cavanna
    Giancarlo Bisagni
    Federico Piacentini
    Enrico Tagliafico
    Katia Cagossi
    Guido Ficarra
    Aleix Prat
    Pierfranco Conte
    Valentina Guarneri
    npj Breast Cancer, 7
  • [32] Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
    Ditsch, Nina
    Schmidt, Marcus
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2019, 79 (12) : 1328 - 1335
  • [33] Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer
    Griguolo, Gaia
    Dieci, Maria Vittoria
    Pare, Laia
    Miglietta, Federica
    Generali, Daniele Giulio
    Frassoldati, Antonio
    Cavanna, Luigi
    Bisagni, Giancarlo
    Piacentini, Federico
    Tagliafico, Enrico
    Cagossi, Katia
    Ficarra, Guido
    Prat, Aleix
    Conte, Pierfranco
    Guarneri, Valentina
    NPJ BREAST CANCER, 2021, 7 (01)
  • [34] Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer
    Ferro, Antonella
    Campora, Michela
    Caldara, Alessia
    De Lisi, Delia
    Lorenzi, Martina
    Monteverdi, Sara
    Mihai, Raluca
    Bisio, Alessandra
    Dipasquale, Mariachiara
    Caffo, Orazio
    Ciribilli, Yari
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (12)
  • [35] The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
    Grinshpun, Albert
    Sandusky, Zachary M.
    Jeselsohn, Rinath
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (01) : 169 - 181
  • [36] Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer
    Basaran, Gul A.
    Twelves, Chris
    Dieras, Veronique
    Cortes, Javier
    Awada, Ahmad
    CANCER TREATMENT REVIEWS, 2018, 63 : 144 - 155
  • [37] The clinical impact of NOLUS in unresectable/metastatic hormone receptor-positive (HR+)/HER2-negative breast cancer
    Tajiri, Wakako
    Nakamura, Yoshiaki
    Kawasaki, Junji
    Koi, Yumiko
    Akiyoshi, Sayuri
    Koga, Chinami
    Tokunaga, Eriko
    CANCER RESEARCH, 2024, 84 (09)
  • [38] Clinical Validation of BCT Scores With Prognostic Factors in Hormone Receptor-positive, HER2-negative Early Breast Cancer
    Lee, Jeeyeon
    Kim, Won Hwa
    Jung, Jin Hyang
    Kim, Wan Wook
    Park, Chan Sub
    Lee, Ryu Kyung
    Park, Jee Young
    Chae, Yee Soo
    Lee, Soo Jung
    Kim, Hye Jung
    Park, Ji-Young
    Park, Ho Yong
    IN VIVO, 2019, 33 (06): : 2133 - 2139
  • [39] Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer
    Yu, Ke-Da
    Jiang, Yi-Zhou
    Hao, Shuang
    Shao, Zhi-Ming
    BMC MEDICINE, 2015, 13
  • [40] Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer
    Ke-Da Yu
    Yi-Zhou Jiang
    Shuang Hao
    Zhi-Ming Shao
    BMC Medicine, 13
12345